Charani ranasinghe
Australian National University, Australia
Biography
Charani Ranasinghe completed her PhD from University of Western Australia. She is the Group Leader of the Molecular Mucosal Vaccine Immunology Group at the JCSMR, Australian National University. She was the first to discover that IL-13 plays an important role in modulating CD8 T cell avidity in a vaccine route dependent manner. Her team has recently developed two novel IL-4R antagonist and IL-13Ra2 adjuvanted vaccine platforms that can induce high quality systemic/ Mucosal CD8 T and B cell immunity.
Abstract
Abstract : Unique IL-4R antagonist and IL-13Ra2 adjuvanted pox viral vector-based HIV vaccines
Speaker Presentations
Speaker PDFs
Speaker PPTs Click Here